PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.\', \'Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden.\', \'Department of Communicable Disease Control and Prevention, Region Stockholm, Stockholm, Sweden.\', \'Department of Medical Sciences, Uppsala University, Uppsala, Sweden.\', \'The George Institute for Global Health, University of New South Wales, Sydney, Australia.\', \'Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.\', \'Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pmed.1003820
?:hasPublicationType
?:journal
  • PLoS medicine
is ?:pmid of
?:pmid
?:pmid
  • 34648516
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.914
?:rankingScore_hIndex
  • 184
?:title
  • HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34648516>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34648516>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all